Albert David Ltd. (ALBERTDAVD) Share Price Rises 11.09% Today; Stock Enters Top Gainers List

Albert David Ltd. rose to Rs 804.10, up 11.09% today, taking its market capitalisation to Rs 413.11 crore and placing the stock among today’s notable gainers.

Albert David Ltd. Share Price moved into focus on 07 August 2026 after the stock rose to Rs 804.10, up Rs 80.25 or 11.09% from the previous close of Rs 723.85. With market capitalisation at Rs 413.11 crore, the company sits in the Micro Cap category, and today’s sharp move was strong enough to place it among the notable top gainer names being tracked in Stock Market Today coverage.

The supplied data confirms the price event clearly: Albert David Ltd. Share Price Today opened at Rs 860, touched a day high of Rs 860, and traded as low as Rs 802.50 before holding near Rs 804.10 at the time of the article. That intraday pattern points to a gap-up start followed by some cooling from the opening peak, but the stock still retained a sizeable share price gain versus the previous session.

What is not established by the supplied data is a company-specific catalyst. So, while Albert David Ltd. Stock News is trending because of the price rise and its presence among market movers, the verified figures support the move itself rather than any confirmed reason behind it. For investors following Albert David Ltd. Share Price, the next checkpoints are trading volume, relative valuation within Pharmaceuticals & Drugs, profitability ratios such as ROE and ROCE, and whether the stock’s market-cap scale justifies continued attention on Univest and across Share Market Today screens.

Albert David Ltd. (ALBERTDAVD) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 804.1
Previous Close	Rs 723.85
Today's Change	+Rs 80.25 (+11.09%)
Day Open	Rs 860
Day High	Rs 860
Day Low	Rs 802.5
Current Volume (BSE)	4,767
BSE Traded Volume	4,767
NSE Traded Volume	11,721
Combined NSE + BSE Volume	16,488
Turnover	Rs 0.38 crore
Market Capitalisation	Rs 413.11 crore
Market Cap Category	Micro Cap

Albert David Ltd. (ALBERTDAVD) traded at Rs 804.1. versus the previous close of Rs 723.85, a rise of 11.09%. The stock opened at Rs 860, reached Rs 860, touched Rs 802.5. Reported volume was 4,767.

Albert David Ltd. (ALBERTDAVD) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 413.11 crore
P/E Ratio	18.31x
P/B Ratio	1.06x
ROE	13.46%
ROCE	18.1%
EPS	Rs 39.54
Dividend Yield	0.69%

Albert David Ltd. was valued at a P/E ratio of 18.31x, a P/B ratio of 1.06x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 13.46% and ROCE of 18.1%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 39.54, dividend yield of 0.69%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Albert David Ltd. Fundamental Analysis shows a micro cap healthcare company trading at moderate valuation multiples relative to its industry benchmark, while profitability metrics such as ROE and ROCE stand above the industry median. That combination adds useful context to today’s move, even though it does not by itself explain the trigger.

Albert David Ltd. Market Cap stands at Rs 413.11 crore, which places the company below the industry average market capitalisation of Rs 500.48 crore but well above the industry median of Rs 144.63 crore within the same Pharmaceuticals & Drugs benchmark set. That means the company is small in absolute listed-market terms, yet not at the bottom end of the peer universe.

On valuation, the stock trades at a P/E ratio of 18.31. Compared with the same-industry benchmark median P/E of 25.99 and average P/E of 81.5 across 104 companies, Albert David Ltd. Share Price appears to be valued below both the median and average on earnings. The P/B ratio is 1.06, again below the benchmark median P/B of 1.86 and average P/B of 2.51 across 136 companies. That matters because it suggests the market is not assigning an especially rich valuation multiple relative to the wider industry set.

Profitability gives a more supportive picture. ROE is 13.46%, which is above the industry median ROE of 10.59% and above the average ROE of 8.23%. ROCE is 18.1%, also above the median ROCE of 12.98% and the average ROCE of 15.71%. In simple terms, the company’s supplied return ratios are better than the industry’s central tendency, which can help explain why investors may keep Albert David Ltd. Share Price on their watchlists after a strong session.

The EPS is Rs 39.54, which shows the earnings attributable to each share based on the supplied data. Dividend yield stands at 0.69, indicating a modest historical payout relative to the current stock price. While a dividend yield of 0.69 is not high, it still adds another layer to the company’s financial profile. Univest also notes that the combination of a 1.06 P/B ratio and 18.31 P/E ratio places the stock in a valuation zone that looks restrained compared with several industry names. The next step is to compare that profile with the sector benchmark and a selected peer set rather than viewing Albert David Ltd. Stock Analysis in isolation.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	18.31x
Benchmark Median P/E	25.99x
Benchmark Average P/E	81.5x
Benchmark P/E Range	3.3x to 3,493.04x
Company P/B Ratio	1.06x
Benchmark Median P/B	1.86x
Company ROE	13.46%
Benchmark Median ROE	10.59%
Company ROCE	18.1%
Benchmark Median ROCE	12.98%
Company Market Capitalisation	Rs 413.11 crore
Benchmark Median Market Cap	Rs 144.63 crore

Albert David Ltd. (ALBERTDAVD) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Albert David Ltd. (ALBERTDAVD) has a P/E ratio of 18.31x, which is below the benchmark median of 25.99x, a difference of -29.55%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Albert David Ltd. (ALBERTDAVD) has a ROE of 13.46%, which is above the benchmark median of 10.59%, a difference of +27.1%. Albert David Ltd. (ALBERTDAVD) has a ROCE of 18.1%, which is above the benchmark median of 12.98%, a difference of +39.45%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Within Healthcare and the Pharmaceuticals & Drugs industry, Albert David Ltd. sits in a benchmark universe of 137 companies. Its valuation is below the industry median on both P/E and P/B, while its ROE and ROCE are above the median, creating a mixed-to-constructive comparative profile.

The company belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The sector snapshot uses the benchmark scope of the same industry and covers 137 companies, which gives a meaningful base for comparison. Albert David Ltd. Share Price is therefore being assessed against a broad listed peer universe rather than a narrow one-off comparison.

The company’s P/E ratio of 18.31 sits below the industry median of 25.99 and far below the industry average of 81.5, with the benchmark range running from 3.3 to 3493.04 across 104 companies with available P/E data. That wide range shows why median comparison is often more useful than average comparison in this industry. On P/B, Albert David trades at 1.06, lower than the benchmark median of 1.86 and average of 2.51, with a range from -16.76 to 16.42 across 136 companies.

On profitability, the relative picture improves. ROE at 13.46% exceeds the median of 10.59% and the average of 8.23%. ROCE at 18.1% is also stronger than the median 12.98% and average 15.71%. That suggests the market is currently assigning Albert David Ltd. Share Price a valuation that is lower than the industry centre on key multiples, despite return ratios that are above the industry norm.

Market-cap positioning adds further context. Albert David’s Rs 413.11 crore market capitalisation is higher than the industry median of Rs 144.63 crore but below the industry average of Rs 500.48 crore, while the full market-cap range spans Rs 6.16 crore to Rs 3,060.41 crore. For readers tracking Albert David Ltd. Share Price Today on Univest, this makes the stock notable as a smaller pharma name with above-median returns and below-median valuation metrics inside its benchmark universe.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,060.41	31.3	0.46	-2.89	-0.26
Hikal Ltd.	HIKAL	2,862.43	0	2.29	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,652.52	40.87	8.32	28.21	26.35
Beta Drugs Ltd.	BETA	2,623.92	67.31	10.65	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,571.92	0	3.06	0	5.36

Albert David Ltd. (ALBERTDAVD) has a P/E ratio of 18.31x compared with the displayed peer median of 31.3x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.46% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 18.1% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Albert David Ltd. (ALBERTDAVD) has a market capitalisation of Rs 413.11 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Peer comparison shows Albert David positioned at a lower valuation multiple than several listed Pharmaceuticals & Drugs peers, while its profitability ratios sit in the middle-to-upper part of the comparison set rather than at either extreme.

Against Dishman Carbogen Amcis Ltd., which has a market capitalisation of Rs 3,060.41 crore and a P/E of 31.3, Albert David Ltd. Share Price trades at a lower earnings multiple of 18.31. Dishman’s P/B is 0.46, lower than Albert David’s 1.06, but its ROE of -2.89% and ROCE of -0.26% are materially weaker than Albert David’s 13.46% and 18.1%.

Compared with Kwality Pharmaceuticals Ltd., the contrast is sharper on valuation. Kwality trades at a P/E of 40.87 and P/B of 8.32, with ROE of 28.21% and ROCE of 26.35%. Beta Drugs Ltd. carries an even higher P/E of 67.31 and P/B of 10.65, alongside ROE of 18.65% and ROCE of 22.17%. In both cases, peer profitability is stronger, but the valuation premiums are also far higher than Albert David’s.

Hester Biosciences Ltd. offers an interesting lower-P/E comparison, with a P/E of 15.31, but its P/B of 4.58 is well above Albert David’s 1.06. Hester’s ROE of 16.17% and ROCE of 14.12% show a mixed comparison: stronger ROE than Albert David but lower ROCE. Sai Parenteral’s Ltd. trades at a P/E of 167.74 with ROE of 13.9% and ROCE of 12.97%, which again highlights how much richer some peer earnings multiples are.

Market-cap comparisons are also important. Albert David’s Rs 413.11 crore valuation is well below the peer set ranging from Rs 2,072.78 crore for Hester Biosciences to Rs 3,060.41 crore for Dishman Carbogen Amcis. So Albert David Ltd. Stock Analysis points to a significantly smaller company, but one with return ratios that compare credibly and valuation multiples that remain restrained relative to several peer names tracked by Univest.

Why Investors Are Watching Albert David Ltd.

Investors are watching because Albert David Ltd. Share Price combined a double-digit day gain with below-median sector valuation and above-median profitability metrics. That does not establish a catalyst, but it does explain why the stock has moved onto active watchlists today.

• The stock rose 11.09% to Rs 804.10 from a previous close of Rs 723.85.
• It opened at Rs 860, which was also the day high, before easing to a day low of Rs 802.50.
• Market capitalisation stands at Rs 413.11 crore, keeping it in the Micro Cap segment.
• Total traded volume across exchanges was 16,488 shares, with turnover of Rs 0.38 crore.
• The P/E ratio of 18.31 and P/B ratio of 1.06 are below industry medians of 25.99 and 1.86.
• ROE of 13.46% and ROCE of 18.1% are above industry medians of 10.59% and 12.98%.
• The stock operates in Healthcare, specifically Pharmaceuticals & Drugs, where 137 companies form the benchmark set.

What investors may monitor next is whether Albert David Ltd. Share Price continues to hold a meaningful portion of today’s gain, how turnover evolves from here, and whether the market continues to value the company at a discount to several peer multiples despite stronger-than-median return ratios. On Univest, that makes the stock relevant as a price-action story supported by comparative valuation context rather than by any verified corporate trigger in the supplied data.

About Albert David Ltd.

Albert David Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry. That places the company within a broad listed healthcare manufacturing universe where valuation and profitability comparisons are especially important for understanding stock performance.

Based on the supplied company classification, Albert David Ltd. is part of India’s listed pharmaceuticals ecosystem. In market terms, it is a micro cap company with a market capitalisation of Rs 413.11 crore, which makes it much smaller than several industry peers in the comparison set but still larger than the industry median company by market value.

The company’s financial market profile suggests a business that the market currently prices more conservatively than many peers. Albert David Ltd. Share Price reflects a P/E ratio of 18.31 and a P/B ratio of 1.06, while its profitability indicators stand at ROE of 13.46% and ROCE of 18.1%. That matters because companies in pharmaceuticals are often judged not just on market size, but also on the relationship between valuation and returns.

Its EPS of Rs 39.54 indicates the earnings attributable to each share in the supplied data, and the dividend yield of 0.69 shows a modest historical cash payout relative to the current stock price. For investors scanning Albert David Ltd. Latest News, these figures help frame the company not simply as a stock rising today, but as a listed pharmaceuticals business whose market valuation, profitability and price action are all currently part of the conversation on Univest.

Track Albert David Ltd. Share Price on Univest

Use Albert David Ltd. (ALBERTDAVD) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Users tracking Albert David Ltd. Share Price on Univest can follow live share price moves, market capitalisation, 52-week levels, valuation ratios, profitability indicators and broader stock analysis in one place. For a stock like this, where today’s gain is clear but the supplied data does not establish a company-specific cause, a platform view becomes useful because it helps separate price action from financial context.

Univest also helps users monitor Albert David Ltd. Share Price Today alongside sector comparisons, peer valuation data, ROE, ROCE, EPS, dividend yield and broader Healthcare market context. That makes it easier to keep Albert David Ltd. Stock News, Albert David Ltd. Shareholding Pattern updates when available, and ongoing market insights in view without turning a single day’s move into a long-term conclusion.

Frequently Asked Questions

Why is Albert David Ltd. Share Price in focus today?

Ans. Albert David Ltd. Share Price is in focus because the stock rose 11.09% today to Rs 804.10 from Rs 723.85. That single-session gain placed the micro cap pharmaceuticals stock among notable top gainer names being tracked today.

What is Albert David Ltd. Share Price Today?

Ans. Albert David Ltd. Share Price Today was Rs 804.10 at the time of the article. The stock was up Rs 80.25 or 11.09% from the previous close of Rs 723.85, highlighting a strong day move in early trade.

How did Albert David Ltd. trade during the session?

Ans. The stock opened at Rs 860, which was also the day high, and later slipped to a day low of Rs 802.50. Even after easing from the opening level, it continued to hold a sizeable gain over the prior close.

What is the market capitalisation of Albert David Ltd.?

Ans. Albert David Ltd. had a market capitalisation of Rs 413.11 crore in the supplied data. That places it in the Micro Cap category, making today’s 11.09% rise especially noticeable in market-mover screens and stock news filters.

Does the supplied data confirm why Albert David Ltd. is rising today?

Ans. The supplied data confirms the price rise and intraday trading pattern, but it does not establish a company-specific catalyst. What is verified is the 11.09% gain, the price range, turnover and the stock’s valuation and profitability context.

Is Albert David Ltd. expensive compared with its industry on P/E?

Ans. Albert David trades at a P/E of 18.31, which is below the same-industry median of 25.99 and well below the average of 81.5. On supplied earnings multiples alone, the stock is not priced above the industry benchmark.

How does Albert David Ltd. compare on P/B ratio?

Ans. The stock’s P/B ratio is 1.06, lower than the industry median P/B of 1.86 and average of 2.51. That suggests Albert David Ltd. Share Price is valued more conservatively than the broader Pharmaceuticals & Drugs benchmark on book value.

What do ROE and ROCE indicate for Albert David Ltd.?

Ans. Albert David reported ROE of 13.46% and ROCE of 18.1% in the supplied figures. Both are above the industry medians of 10.59% and 12.98%, indicating comparatively stronger return metrics than the benchmark centre.

What are the EPS and dividend yield of Albert David Ltd.?

Ans. The supplied data shows EPS of Rs 39.54 and dividend yield of 0.69 for Albert David Ltd. EPS reflects earnings attributable to each share, while dividend yield shows the historical payout relative to the current market price.

How much trading volume was recorded in Albert David Ltd. today?

Ans. Total traded volume stood at 16,488 shares across exchanges, with BSE volume at 4,767 and NSE volume at 11,721. Reported turnover was Rs 0.38 crore, giving useful context to today’s price rise and trading participation.